Lonza Vacaville
multi-product cGMP mammalian manufacturing facility
PROCESS SCOPE · VERIFY THE MATCH
General biologics, cell-culture, or network-wide wording is not enough to establish that a named US site supports your molecule, expression host, commercial phase, or unconjugated mAb scope.
multi-product cGMP mammalian manufacturing facility
custom production of mammalian biopharmaceuticals; GS-system for monoclonal antibodies and recombinant proteins
Commercial-scale mammalian cell culture; monoclonal antibodies.
Protein-specific scope unknown in reviewed evidence.
single-use biologics drug substance manufacturing
mammalian cell line technology (GPEx) and development/manufacturing for new biological entities and biosimilars
Seattle-specific GMP mammalian manufacturing and cell-line development.
CHO/HEK293 cell-line and DNA-to-IND process development.
Costa Mesa: early phase. Tustin: clinical and commercial manufacturing.
antibodies, proteins, enzymes, and mRNA; stable mammalian cell line development
bioconjugates and ADCs (antibodies, linker payloads, bioconjugation)
Vendor capability wording is a starting point for qualification; it is not independent evidence of process performance, GMP status, or molecule fit.
← Return to the site comparison
A named-site statement is more useful than a network-wide capability list.
AGC’s Seattle facility page explicitly identifies GMP mammalian manufacturing and mammalian cell-line development at Seattle.
This resolves the earlier network-versus-site gap for broad mammalian scope. Molecule-specific suite fit and open slots still need confirmation. Source & date
Fujifilm’s July 8, 2026 announcement describes Holly Springs as commercial-scale mammalian cell culture manufacturing and says it makes monoclonal antibodies.
This is a vendor manufacturing-scope claim. Participation in FDA PreCheck does not establish product approval or a clean inspection. Source & date
Avid’s Costa Mesa page documents CHO and HEK293 cell-line development, alongside process, analytical and formulation development for DNA-to-IND programs.
Development host capability does not establish the exact host, vessel train or commercial manufacturing scope for your program. Source & date
Avid identifies Costa Mesa as its early-phase campus and Tustin as the campus for clinical and commercial manufacturing.
Do not apply Avid’s commercial company-wide claim to Costa Mesa. The transfer plan and each site’s manufacturing role still need a written proposal. Source & date